| References |
|
|
Abdallah A,
Sato H,
Grutters JC et al.
(2003)
Inhibitor kappa B‐alpha (IkappaB‐alpha) promoter polymorphisms in UK and Dutch sarcoidosis.
Genes and Immunity
4(6):
450–454.
|
|
|
Abe S,
Yamaguchi E,
Makimura S et al.
(1987)
Association of HLA‐DR with sarcoidosis. Correlation with clinical course.
Chest
92(3):
488–490.
|
|
|
Akahoshi M,
Ishihara M,
Remus N et al.
(2004)
Association between IFNA genotype and the risk of sarcoidosis.
Human Genetics
114(5):
503–509.
|
|
|
Baughman RP and
Iannuzzi M
(2003)
Tumour necrosis factor in sarcoidosis and its potential for targeted therapy.
BioDrugs
17(6):
425–431.
|
|
|
Bogunia‐Kubik K,
Koscinska K,
Suchnicki K and
Lange A
(2006)
HSP70‐hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis.
International Journal of Immunogenetics
33(2):
135–140.
|
|
|
Bohnert A,
Schurmann M,
Hartung A et al.
(2002)
No linkage of the interleukin‐4 receptor locus on chromosome 16p11.2‐12.1 with sarcoidosis in German multiplex families).
European Journal of Immunogenetics
29(3):
269–272.
|
|
|
Bombieri C,
Belpinati F,
Pignatti PF and
Luisetti M
(2003)
Comment on ‘CFTR gene mutations in sarcoidosis’.
European Journal of Human Genetics
11(8):
553–554.
|
|
|
Bombieri C,
Luisetti M,
Belpinati F et al.
(2000)
Increased frequency of CFTR gene mutations in sarcoidosis: a case/control association study.
European Journal of Human Genetics
8(9):
717–720.
|
|
|
Brewerton DA,
Cockburn C,
James DC,
James DG and
Neville E
(1977)
HLA antigens in sarcoidosis.
Clinical & Experimental Immunology
27(2):
227–229.
|
|
|
Fischer A,
Nothnagel M,
Schurmann M et al.
(2010)
A genome‐wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers.
Chest
138(1):
151–157.
|
|
|
Grutters JC,
Sato H,
Pantelidis P et al.
(2002)
Increased frequency of the uncommon tumor necrosis factor ‐857T allele in British and Dutch patients with sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
165(8):
1119–1124.
|
|
|
Grutters JC,
Sato H,
Pantelidis P et al.
(2003)
Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
20(1):
20–27.
|
|
|
Guleva I and
Seitzer U
(2000)
Vitamin D receptor gene polymorphism in patients with sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
162(2 Pt 1):
760–761.
|
|
|
Handa T,
Nagai S,
Ito I et al.
(2005)
Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis.
Respiration
72(3):
243–248.
|
|
|
Hedfors E and
Lindstrom F
(1983)
HLA‐B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis.
Tissue Antigens
22(3):
200–203.
|
|
|
Hizawa N,
Yamaguchi E,
Furuya K et al.
(1999)
The role of the C‐C chemokine receptor 2 gene polymorphism V64I (CCR2‐64I) in sarcoidosis in a Japanese population.
American Journal of Respiratory and Critical Care Medicine
159(6):
2021–2023.
|
|
|
Hofmann S,
Fischer A,
Till A et al.
(2011)
A genome‐wide association study reveals evidence of association with sarcoidosis at 6p12.1.
European Respiratory Journal
38(5):
1127–1135.
|
|
|
Hofmann S,
Franke A,
Fischer A et al.
(2008)
Genome‐wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.
Nature Genetics
40(9):
1103–1106.
|
|
|
Hutyrova B,
Pantelidis P,
Drabek J et al.
(2002)
Interleukin‐1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis.
American Journal of Respiratory and Critical Care Medicine
165(2):
148–151.
|
|
|
Iannuzzi MC
(2007)
Genetics of sarcoidosis.
Seminars in Respiratory and Critical Care Medicine
28(1):
15–21.
|
|
|
Iannuzzi MC and
Fontana JR
(2011)
Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.
JAMA
305(4):
391–399.
|
|
|
Iannuzzi MC,
Maliarik MJ,
Poisson LM and
Rybicki BA
(2003)
Sarcoidosis susceptibility and resistance HLA‐DQB1 alleles in African Americans.
American Journal of Respiratory and Critical Care Medicine
167(9):
1225–1231.
|
|
|
Ishihara M,
Ishida T,
Inoko H et al.
(1996)
HLA serological and class II genotyping in sarcoidosis patients in Japan.
Japanese Journal of Ophthalmology
40(1):
86–94.
|
|
|
Ishihara M,
Ohno S,
Ishida T et al.
(1995)
Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis.
Tissue Antigens
46(1):
59–62.
|
|
|
Janssen R,
Grutters JC,
Ruven HJ et al.
(2004a)
No association between interleukin‐18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients.
Tissue Antigens
63(6):
578–583.
|
|
|
Janssen R,
Sato H,
Grutters JC et al.
(2004b)
The Clara cell10 adenine38guanine polymorphism and sarcoidosis susceptibility in Dutch and Japanese subjects.
American Journal of Respiratory and Critical Care Medicine
170(11):
1185–1187.
|
|
|
Kruit A,
Grutters JC,
Ruven HJ et al.
(2006)
Transforming growth factor‐beta gene polymorphisms in sarcoidosis patients with and without fibrosis.
Chest
129(6):
1584–1591.
|
|
|
Kunikane H,
Abe S,
Tsuneta Y et al.
(1987)
Role of HLA‐DR antigens in Japanese patients with sarcoidosis.
American Review of Respiratory Disease
135(3):
688–691.
|
|
|
Kunikane H,
Abe S,
Yamaguchi E et al.
(1994)
Analysis of restriction fragment length polymorphism for the HLA‐DR gene in Japanese patients with sarcoidosis.
Thorax
49(6):
573–576.
|
|
|
Labunski S,
Posern G,
Ludwig S et al.
(2001)
Tumour necrosis factor‐alpha promoter polymorphism in erythema nodosum.
Acta Dermato‐Venereologica
81(1):
18–21.
|
|
|
Maliarik MJ,
Rybicki BA,
Malvitz E et al.
(1998)
Angiotensin‐converting enzyme gene polymorphism and risk of sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
158(5 Pt 1):
1566–1570.
|
|
|
Morohashi K,
Takada T,
Omori K,
Suzuki E and
Gejyo F
(2003)
Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis.
Chest
123(5):
1520–1526.
|
|
|
Murakozy G,
Gaede KI,
Zissel G,
Schlaak M and
Müller‐Quernheim J
(2001)
Analysis of gene polymorphisms in interleukin‐10 and transforming growth factor‐beta 1 in sarcoidosis.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
18(2):
165–169.
|
|
|
Newman LS,
Rose CS,
Bresnitz EA et al.
(2004)
A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
American Journal of Respiratory and Critical Care Medicine
170(12):
1324–1330.
|
|
|
Nicod LP and
Isler P
(1997)
Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L.
American Journal of Respiratory Cell and Molecular Biology
17(1):
91–96.
|
|
|
Ohchi T,
Shijubo N,
Kawabata I et al.
(2004)
Polymorphism of Clara cell 10‐kD protein gene of sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
169(2):
180–186.
|
|
|
Pabst S,
Baumgarten G,
Stremmel A et al.
(2006)
Toll‐like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.
Clinical & Experimental Immunology
143(3):
420–426.
|
|
|
Pabst S,
Franken T,
Schonau J et al.
(2011)
Transforming growth factor‐ beta gene polymorphisms in different phenotypes of sarcoidosis.
European Respiratory Journal
38(1):
169–175.
|
|
|
Papaioannides D,
Fotinou M,
Korantzopoulos P et al.
(2004)
Sarcoidosis associated with interferon‐alpha therapy for chronic Hepatitis C.
Medical Science Monitor
10(1):
CS5–7.
|
|
|
Pasturenzi L,
Martinetti M,
Cuccia M et al.
(1993)
HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia‐Padova sarcoidosis study group.
Chest
104(4):
1170–1175.
|
|
|
Petrek M,
Drabek J,
Kolek V et al.
(2000)
CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
162(3 Pt 1):
1000–1003.
|
|
|
Richeldi L,
Sorrentino R and
Saltini C
(1993)
HLA‐DPB1 glutamate 69: a genetic marker of beryllium disease.
Science
262(5131):
242–244.
|
|
|
Rossman MD,
Stubbs J,
Lee CW et al.
(2002)
Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.
American Journal of Respiratory and Critical Care Medicine
165(6):
788–794.
|
|
|
Rossman MD,
Thompson B,
Frederick M et al.
(2003)
HLA‐DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.
American Journal of Human Genetics
73(4):
720–735.
|
|
|
Rybicki BA and
Iannuzzi MC
(2007)
Epidemiology of sarcoidosis: recent advances and future prospects.
Seminars in Respiratory and Critical Care Medicine
28(1):
22–35.
|
|
|
Rybicki BA,
Maliarik MJ,
Poisson LM and
Iannuzzi MC
(2004)
Sarcoidosis and granuloma genes: a family based study in African‐Americans.
European Respiratory Journal
24(2):
251–257.
|
|
|
Rybicki BA,
Walewski JL,
Maliarik MJ et al.
(2005)
The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites.
American Journal of Human Genetics
77(3):
491–499.
|
|
|
Schurmann M,
Albrecht M,
Schwinger E and
Stuhrmann M
(2002)
CFTR gene mutations in sarcoidosis.
European Journal of Human Genetics
10(11):
729–732.
|
|
|
Schurmann M,
Reichel P,
Muller‐Myhsok B et al.
(2001)
Results from a genome‐wide search for predisposing genes in sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
164(5):
840–846.
|
|
|
Seitzer U,
Swider C,
Stuber F et al.
(1997)
Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.
Cytokine
9(10):
787–790.
|
|
|
Sharma OP
(1996)
Vitamin D, calcium, and sarcoidosis.
Chest
109(2):
535–539.
|
|
|
Shijubo N,
Itoh Y,
Shigehara K et al.
(2000)
Association of Clara cell 10‐kDa protein, spontaneous regression and sarcoidosis.
European Respiratory Journal
16(3):
414–419.
|
|
|
de Smet MD and
Ramadan A
(2001)
Circulating antibodies to inducible heat shock protein 70 in patients with uveitis.
Ocular Immunology and Inflammation
9(2):
85–92.
|
|
|
Smith G,
Brownell I,
Sanchez M and
Prystowsky S
(2008)
Advances in the genetics of sarcoidosis.
Clinical Genetics
73(5):
401–412.
|
|
|
Somoskovi A,
Zissel G,
Seitzer U et al.
(1999)
Polymorphisms at position ‐308 in the promoter region of the TNF‐alpha and in the first intron of the TNF‐beta genes and spontaneous and lipopolysaccharide‐induced TNF‐alpha release in sarcoidosis.
Cytokine
11(11):
882–887.
|
|
|
Spagnolo P,
Renzoni EA,
Wells AU et al.
(2003)
C‐C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome.
American Journal of Respiratory and Critical Care Medicine
168(10):
1162–1166.
|
|
|
Spagnolo P,
Renzoni EA,
Wells AU et al.
(2005)
C‐C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
172(6):
721–728.
|
|
|
Sverrild A,
Backer V,
Kyvik KO et al.
(2008)
Heredity in sarcoidosis: a registry‐based twin study.
Thorax
63(10):
894–896.
|
|
|
Takada T,
Suzuki E,
Morohashi K and
Gejyo F
(2002)
Association of single nucleotide polymorphisms in the IL‐18 gene with sarcoidosis in a Japanese population.
Tissue Antigens
60(1):
36–42.
|
|
|
Unanue ER and
Allen PM
(1987)
The basis for the immunoregulatory role of macrophages and other accessory cells.
Science
236(4801):
551–557.
|
|
|
Valentonyte R,
Hampe J,
Croucher PJ et al.
(2005a)
Study of C‐C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis.
American Journal of Respiratory and Critical Care Medicine
171(10):
1136–1141.
|
|
|
Valentonyte R,
Hampe J,
Huse K et al.
(2005b)
Sarcoidosis is associated with a truncating splice site mutation in BTNL2.
Nature Genetics
37(4):
357–364.
|
|
|
Veltkamp M,
Grutters JC,
van Moorsel CHM,
Ruven HJT and
van den Bosch JMM
(2006)
Toll‐like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.
Clinical & Experimental Immunology
145(2):
215–218.
|
|
|
Wang Z,
White PS,
Petrovic M et al.
(1999)
Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA‐DPB1 and ‐DPA1 alleles.
Journal of Immunology
163(3):
1647–1653.
|
|
|
Zissel G,
Homolka J,
Schlaak J,
Schlaak M and
Müller‐Quernheim J
(1996)
Anti‐inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis.
American Journal of Respiratory and Critical Care Medicine
154(3 Pt 1):
713–719.
|
|
|
Zorzetto M,
Bombieri C,
Ferrarotti I et al.
(2002)
Complement receptor 1 gene polymorphisms in sarcoidosis.
American Journal of Respiratory Cell and Molecular Biology
27(1):
17–23.
|
| Further Reading |
|
|
Iannuzzi MC and
Fontana JR
(2011)
Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.
JAMA
305(4):
391–399.
|
|
|
Iannuzzi MC,
Rybicki BA and
Teirstein AS
(2007)
Sarcoidosis.
New England Journal of Medicine
357(21):
2153–2165.
|
